A subset of MMR‐proficient colon cancers responds to neoadjuvant immunotherapy
Tan et al. reveal that a distinct subset of early‐stage pMMR colon cancers can respond to neoadjuvant immunotherapy. In the NICHE‐2 trial, responders (26%) were characterized by chromosomal instability, TP53 mutations, and proliferative cell‐cycle programs, whereas nonresponders showed metabolic and stromal reprogramming with TGF‐β‐driven ...
Eleonora Piumatti +3 more
wiley +1 more source
Association of Life's Essential 8 with risk of incident cardiovascular disease and mortality among adults with chronic kidney disease. [PDF]
Huo Z +13 more
europepmc +1 more source
\u3cem\u3eDonde habite el olvido\u3c/em\u3e: Poetry of Nonbeing [PDF]
Seybolt, Richard A.
core +1 more source
The cancer problem is increasing globally with projections up to the year 2050 showing unfavourable outcomes in terms of incidence and cancer‐related deaths. The main challenges are prevention, improved therapeutics resulting in increased cure rates and enhanced health‐related quality of life.
Ulrik Ringborg +43 more
wiley +1 more source
Life's essential 8 and risk of progression to diabetes among young adults with prediabetes. [PDF]
Lovre D, Zu Y, Cheung HY, Yoshida Y.
europepmc +1 more source
Human Death as Neocortical Death: The Ethical Context [PDF]
Weber, Leonard J.
core +1 more source
Cell surface interactome analysis identifies TSPAN4 as a negative regulator of PD‐L1 in melanoma
Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD‐L1 interactome of melanoma cells. TSPAN4 negatively regulates PD‐L1 expression and lateral mobility by limiting its interaction with CMTM6 and promoting PD‐L1 degradation.
Guus A. Franken +7 more
wiley +1 more source
Pesticide exposure and cardiovascular health in non-CVD mortality population: novel evidence from NHANES 2007-2018 using Life's Essential 8. [PDF]
He J, Wang H, Li X.
europepmc +1 more source
HCI considerations in designing a Second Life virtual therapeutic community for the support & treatment of people with Borderline Personality Disorder [PDF]
Gnanayutham, Paul +3 more
core
Pharmacologic ascorbate (vitamin C) increases ROS, disrupts cellular metabolism, and induces DNA damage in CRPC cells. These effects sensitize tumors to PARP inhibition, producing synergistic growth suppression with olaparib in vitro and significantly delayed tumor progression in vivo. Pyruvate rescue confirms ROS‐dependent activity.
Nicolas Gordon +13 more
wiley +1 more source

